Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 6.62 USD -2.07% Market Closed
Market Cap: 179.7m USD

Wall Street
Price Targets

ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc

Wall Street analysts forecast ARCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCT is 32.77 USD with a low forecast of 9.09 USD and a high forecast of 71.4 USD.

Lowest
Price Target
9.09 USD
37% Upside
Average
Price Target
32.77 USD
395% Upside
Highest
Price Target
71.4 USD
979% Upside
Arcturus Therapeutics Holdings Inc Competitors:
Price Targets
MGX
Metagenomi Inc
420% Upside
BIOCON
Biocon Ltd
4% Upside
LXRX
Lexicon Pharmaceuticals Inc
100% Upside
TRDA
Entrada Therapeutics Inc
91% Upside
300685
Amoy Diagnostics Co Ltd
29% Upside
688520
Sinocelltech Group Ltd
14% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
25% Upside
NRIX
Nurix Therapeutics Inc
126% Upside

Revenue
Forecast

Revenue Estimate
Arcturus Therapeutics Holdings Inc

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is 8%.

N/A
Past Growth
8%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Arcturus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Arcturus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARCT's stock price target?
Price Target
32.77 USD

According to Wall Street analysts, the average 1-year price target for ARCT is 32.77 USD with a low forecast of 9.09 USD and a high forecast of 71.4 USD.

What is Arcturus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
8%

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is 8%.

Back to Top